Institutional investors purchased a net $331.5 thousand shares of GENT during the quarter ended September 2013. This may signal that the smart money is gaining interest in this company as the 49.80% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WESTFIELD CAPITAL MANAGEMENT CO.... Bought 1.4 Million shares of Gentium SpA
PUTNAM INVESTMENT MANAGEMENT LLC Bought 1.0 Million shares of Gentium SpA
FIDELITY MANAGEMENT & RESEARCH C... Bought 395.5 Thousand shares of Gentium SpA